Clinical trial

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

NCT04855513

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-03-24

PhaseNA

Study timeline

Study start (estimated)2022-03-24Date precision: day

Registry last updated2022-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Preeclampsiaunresolved

Preeclampsia Severeunresolved

High Risk Pregnancyunresolved

Eclampsiaunresolved

Interventions

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Hamad Medical Corporationlead sponsor

Sidra Medicinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04855513 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.